Lianzi Wang

1.1k total citations · 1 hit paper
21 papers, 748 citations indexed

About

Lianzi Wang is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Lianzi Wang has authored 21 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Cancer Research. Recurrent topics in Lianzi Wang's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Lianzi Wang is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Lianzi Wang collaborates with scholars based in China and Saint Kitts and Nevis. Lianzi Wang's co-authors include Shubing Zhang, Huihui Wang, Jiaqing Liu, Xuemei Li, Xian Wu, Tao Li, Yuanhong Xu, Wei Wei, Tao Li and Jilong Shen and has published in prestigious journals such as Journal of Psychiatric Research, BMC Cancer and Journal of Medical Virology.

In The Last Decade

Lianzi Wang

20 papers receiving 736 citations

Hit Papers

Dynamic regulation and functions of mRNA m6A modification 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianzi Wang China 12 317 304 134 72 52 21 748
Huihui Wang China 11 315 1.0× 364 1.2× 99 0.7× 62 0.9× 97 1.9× 32 787
Ruochen Zang China 9 292 0.9× 557 1.8× 115 0.9× 81 1.1× 51 1.0× 13 926
Dina Moustafa Abo El-Ella Egypt 7 135 0.4× 183 0.6× 66 0.5× 69 1.0× 42 0.8× 9 449
Nassiba Taib Qatar 6 127 0.4× 187 0.6× 75 0.6× 94 1.3× 50 1.0× 6 449
Lobna Al-Zaidan Qatar 6 125 0.4× 188 0.6× 66 0.5× 79 1.1× 52 1.0× 7 436
Hin Fung Tsang Hong Kong 15 350 1.1× 177 0.6× 240 1.8× 115 1.6× 61 1.2× 35 802
Jianyong Zhu China 9 137 0.4× 406 1.3× 46 0.3× 49 0.7× 37 0.7× 15 703
Shih-Hwa Chiou Taiwan 5 195 0.6× 399 1.3× 37 0.3× 117 1.6× 25 0.5× 11 683
Zhiqi Song China 8 215 0.7× 700 2.3× 61 0.5× 58 0.8× 33 0.6× 16 1.1k
Salma Younes Qatar 17 283 0.9× 353 1.2× 58 0.4× 40 0.6× 145 2.8× 47 860

Countries citing papers authored by Lianzi Wang

Since Specialization
Citations

This map shows the geographic impact of Lianzi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianzi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianzi Wang more than expected).

Fields of papers citing papers by Lianzi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianzi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianzi Wang. The network helps show where Lianzi Wang may publish in the future.

Co-authorship network of co-authors of Lianzi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lianzi Wang. A scholar is included among the top collaborators of Lianzi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianzi Wang. Lianzi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jin, Lianzi Wang, Mingwang Zhu, et al.. (2025). The change of inflammatory cytokines after antidepressant treatment and correlation with depressive symptoms. Journal of Psychiatric Research. 184. 418–423. 4 indexed citations
4.
Zhu, Xinyue, Yan Zang, Shubing Zhang, et al.. (2024). Current Progress of Ferroptosis Study in Hepatocellular Carcinoma. International Journal of Biological Sciences. 20(9). 3621–3637. 15 indexed citations
5.
Wang, Lianzi, et al.. (2024). Lipopolysaccharide promotes cancer cell migration and invasion through METTL3/PI3K/AKT signaling in human cholangiocarcinoma. Heliyon. 10(8). e29683–e29683. 12 indexed citations
6.
Zhang, Yin, Pei Zhong, Lianzi Wang, et al.. (2023). Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with SFTS. Journal of Infection and Public Health. 16(3). 393–398. 11 indexed citations
7.
Zuo, Yan, Heming Wang, Jiaxing Huang, et al.. (2023). Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study. Journal of Medical Virology. 95(4). e28712–e28712. 9 indexed citations
8.
Zuo, Yan, Dongmei Lv, Lianzi Wang, et al.. (2023). Infection pattern and immunological characteristics of Epstein‐Barr virus latent infection in cervical squamous cell carcinoma. Journal of Medical Virology. 95(4). e28717–e28717. 2 indexed citations
9.
Li, Xiangyun, et al.. (2022). First Study of Bacteremia Caused by Herbaspirillum huttiense in China: A Brief Research Report and Literature Review. Frontiers in Cellular and Infection Microbiology. 12. 882827–882827. 5 indexed citations
10.
Wang, Shanshan, Wei Lv, Tao Li, et al.. (2022). Dynamic regulation and functions of mRNA m6A modification. Cancer Cell International. 22(1). 48–48. 139 indexed citations breakdown →
11.
Wang, Lianzi, et al.. (2022). The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study. Frontiers in Cellular and Infection Microbiology. 12. 725642–725642. 21 indexed citations
12.
Wang, Huihui, Shubing Zhang, Tao Li, et al.. (2022). MicroRNA-146a promotes proliferation, migration, and invasion of HepG2 via regulating FLAP. Cancer Cell International. 22(1). 149–149. 11 indexed citations
13.
Wang, Lianzi, Dongmei Lv, Hylemariam Mihiretie Mengist, et al.. (2021). Epidemiological, Clinical and Laboratory Characteristics of Patients with Brucella Infection in Anhui Province, China. Infection and Drug Resistance. Volume 14. 2741–2752. 14 indexed citations
14.
Wang, Huihui, Xuemei Li, Tao Li, et al.. (2021). Development of a SARS‐CoV‐2 rapid antibody detection kit and study on dynamic changes in antibodies in infected patients. The Clinical Respiratory Journal. 15(5). 499–505. 5 indexed citations
16.
Lv, Wei, Tao Li, Shanshan Wang, et al.. (2021). The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer. Technology in Cancer Research & Treatment. 20. 2203787094–2203787094. 4 indexed citations
17.
Li, Tao, Lianzi Wang, Huihui Wang, et al.. (2020). Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries. European Journal of Clinical Microbiology & Infectious Diseases. 39(12). 2447–2455. 31 indexed citations
18.
Wang, Huihui, Xuemei Li, Tao Li, et al.. (2020). The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases. 39(9). 1629–1635. 338 indexed citations
19.
Wang, Lianzi, Tao Li, Jiaqing Liu, et al.. (2019). Association between glycosylated hemoglobin A1c and bone biochemical markers in type 2 diabetic postmenopausal women: a cross-sectional study. BMC Endocrine Disorders. 19(1). 31–31. 25 indexed citations
20.
Li, Xuemei, Huihui Wang, Tao Li, et al.. (2019). Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma. Current Problems in Cancer. 44(2). 100516–100516. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026